SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000318154-24-000042
Filing Date
2024-10-30
Accepted
2024-10-30 16:06:04
Documents
16
Period of Report
2024-10-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K amgn-20241030.htm   iXBRL 8-K 43512
2 AMGN-2024.9.30 EARNINGS RELEASE amgn-20240930earningsrelea.htm EX-99.1 612242
7 GRAPHIC amgenlogo.jpg GRAPHIC 13030
  Complete submission text file 0000318154-24-000042.txt   898074

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT amgn-20241030.xsd EX-101.SCH 2964
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT amgn-20241030_def.xml EX-101.DEF 17248
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT amgn-20241030_lab.xml EX-101.LAB 30309
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT amgn-20241030_pre.xml EX-101.PRE 17599
18 EXTRACTED XBRL INSTANCE DOCUMENT amgn-20241030_htm.xml XML 4509
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37702 | Film No.: 241410289
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)